Biocytogen

About:

Biocytogen is a biopharmaceutical company that provides integrated solutions for antibody drug development.

Website: https://biocytogen.com

Top Investors: OrbiMed, Remegen, Cowin Capital, 3E Bioventures, SDIC Venture Capital

Description:

Biocytogen is a biopharmaceutical company that provides biomedical communities with integrated solutions for antibody drug development. Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMabTM Mouse), and in vivo/in vitro preclinical validation studies, using gene editing technologies and a state-of-the-art animal facility. Biocytogen works with the world's leading pharmaceutical and biotechnology companies.

Total Funding Amount:

$335M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Daxing, Beijing, China

Founded Date:

2008-11-01

Contact Email:

info(AT)biocytogen.com

Hub Tags:

Exited Unicorn

Founders:

Yuelei Shen

Number of Employees:

1001-5000

Last Funding Date:

2022-08-19

IPO Status:

Public

© 2025 bioDAO.ai